Clinical Trials · NCT00823004

Antagonist/Letrozole in Poor Responders

CompletedPhase 1/Phase 2Gonadorelin (Approved)
Phase
Phase 1/Phase 2
Recruitment status
Completed
Sponsor
Yazd Research & Clinical Center for Infertility
Enrollment
120
Start date
Jun 2008
Locations
1 site, Iran
Primary endpoint
pregnancy rate
View Gonadorelin compound reference